Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

M Glip M 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Naviksha Healthcare Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview M Glip M 2mg/500mg Tablet SR

Combinazione M Glip M 2mg/500mg SR tablets are classified as antidiabetic agents. This dual-action medication treats type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is vital, even with controlled blood sugar, as discontinuation without medical supervision risks elevated glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan, encompassing diet, exercise, and weight management as directed by your healthcare provider. Lifestyle choices are crucial in diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to manage them. Maintain regular meals and carry a rapid-acting glucose source, such as sugary snacks or juice. Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Its suitability for pregnant or breastfeeding women requires medical consultation. Regular blood glucose monitoring is essential, and your doctor may order blood tests to evaluate blood cell counts and liver function.

Primary Ingredients of M Glip M 2mg/500mg Tablet SR

No information provided. Please provide the text you want me to rewrite.

Uses of M Glip M 2mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of M Glip M 2mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the M Glip M 2mg/500mg Tablet SR whole; do not alter its form by chewing, crushing, or breaking. Administer this medicine with a meal.

Common Side effects of M Glip M 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use M Glip M 2mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire tablet without chewing, crushing, or breaking it. The M Glip M 2mg/500mg Sustained-Release tablet should be administered with a meal.

How M Glip M 2mg/500mg Tablet SR works:

M Glip M 2mg/500mg Extended-Release Tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing the body's response to insulin.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and M Glip M 2mg/500mg Tablet SR is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of M Glip M 2mg/500mg SR tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the potential advantages against the risks before prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Prolonged-release M Glip M tablets (2mg/500mg) are contraindicated during lactation due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use the extended-release M Glip M 2mg/500mg tablet cautiously, potentially requiring dosage modification. Consult a physician for guidance. This medication is contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use M Glip M 2mg/500mg Tablet SR cautiously. Dosage modification of M Glip M 2mg/500mg Tablet SR might be necessary. Medical advice is recommended. For those with mild to moderate liver disease, M Glip M 2mg/500mg Tablet SR is typically initiated at a low dose; however, it's contraindicated in patients with severe hepatic dysfunction.

What if you forget to take M Glip M 2mg/500mg Tablet SR :

Should you forget a dose of your M Glip M 2mg/500mg Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About M Glip M 2mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on M Glip M 2mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
M Glip M 2mg/500mg Tablet SR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excess blood lactic acid. This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue use and seek immediate medical attention.
M Glip M 2mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
MGlip M 2mg/500mg SR tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use can result in vitamin B12 deficiency.
Prolonged use of M Glip M 2mg/500mg Tablet SR can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and ataxia. To mitigate this risk, annual supplemental Vitamin B12 is recommended by some researchers.
M Glip M 2mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining M Glip M 2mg/500mg SR tablets with alcohol is unsafe. This combination can lower blood sugar, causing hypoglycemia, and increase the risk of lactic acidosis.
M Glip M 2mg/500mg Tablet...
95
MRP 110
13% off